PCN247 CHARACTERISTICS OF USERS AND PRESCRIBERS OF CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) AMONG MEDICARE AND NON-MEDICARE PATIENTS WITH HUMAN RECEPTOR POSITIVE / HUMAN EPIDERMAL GROWTH FACTOR 2 NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC) BREAST CANCER IN THE UNITED STATES (US), 2015-2018
Petrilla, A., Mohammadi, I., Shen, X., Spurden, D., Mitra, D.Volume:
23
Journal:
Value in Health
DOI:
10.1016/j.jval.2020.04.1716
Date:
May, 2020
File:
PDF, 382 KB
2020